PGIM Jennison Health Sciences Fund - Class Z (PHSZX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD

52.70

-0.22 (-0.42%)

At close: Sep 4, 2026

Fund Assets	1.50B
Expense Ratio	0.88%
Min. Investment	$1,000
Turnover	81.00%
Dividend (ttm)	5.13
Dividend Yield	9.73%
Dividend Growth	-5.09%
Payout Frequency	Annual
Ex-Dividend Date	Dec 19, 2025

Previous Close	52.92
YTD Return	12.34%
1-Year Return	35.78%
5-Year Return	47.84%
52-Week Low	42.43
52-Week High	54.47
Beta (5Y)	0.93
Holdings	54
Inception Date	Jun 30, 1999

About PHSZX

The PGIM Jennison Health Sciences Fund is a mutual fund focused on long-term capital appreciation by investing primarily in the healthcare sector. It targets companies involved in drugs, healthcare services, and biotechnology, aiming to capitalize on the growth potential of these industries. The fund's portfolio is composed of a mix of large-cap healthcare companies, with a significant portion of its assets allocated to top holdings in this sector. Its high-conviction strategy is managed by experienced healthcare specialists, appealing to investors seeking dedicated exposure to the healthcare market. The fund's role in the financial market is to provide a concentrated investment opportunity for those interested in the healthcare industry's potential for growth and innovation.

Fund Family PGIM

Category Health

Performance Rating High

Risk Rating Average

Stock Exchange NASDAQ

Ticker Symbol PHSZX

Share Class Class Z

Index S&P Composite 1500 Health Care TR

Performance

PHSZX had a total return of 35.78% in the past year, including dividends. Since the fund's inception, the average annual return has been 14.74%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
PHLQX	Class R6	0.80%
PHLAX	Class A	1.15%
PJHRX	Class R	1.48%
PHLCX	Class C	1.97%

Top 10 Holdings

59.46% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	17.18%
Prudential Govt Money Mkt Fd	n/a	10.19%
Merck & Co., Inc.	MRK	6.33%
UnitedHealth Group Incorporated	UNH	6.09%
Thermo Fisher Scientific Inc.	TMO	4.61%
Vertex Pharmaceuticals Incorporated	VRTX	3.42%
CVS Health Corporation	CVS	3.16%
Danaher Corporation	DHR	3.12%
argenx SE	ARGX	2.97%
Roivant Sciences Ltd.	ROIV	2.38%

View More Holdings

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 19, 2025	$5.12722	Dec 19, 2025
Dec 20, 2024	$5.40216	Dec 20, 2024
Dec 20, 2023	$1.91322	Dec 20, 2023
Dec 20, 2022	$0.61624	Dec 20, 2022
Dec 20, 2021	$14.02528	Dec 20, 2021
Dec 20, 2019	$1.43164	Dec 20, 2019

Full Dividend History